Journal of Law, Medicine and Ethics 42 (2):244-262 (2014)

Abstract
Efforts to foster transparency in biopharmaceutical regulation are well underway: drug manufacturers are, for example, legally required to register clinical trials and share research results in the United States and Europe. Recently, the policy conversation has shifted toward the disclosure of clinical trial data, not just trial designs and basic results. Here, I argue that clinical trial registration and disclosure of clinical trial data are necessary but insufficient. There is also a need to ensure that regulatory decisions that flow from clinical trials — whether positive (i.e., product approvals) or negative (i.e., abandoned products, product refusals, and withdrawals) — are open to outside scrutiny. Further, a jurisprudence of drug regulation is needed. I develop two arguments motivated by (1) innovation concerns and (2) the value of good governance in support of openly publishing all final decisions for approved, abandoned, refused, and withdrawn products. After articulating why greater transparency in regulatory decision-making is needed, I distil four essential features of a jurisprudence of drug regulation that prescribe policy changes in terms not only of the transparency of regulatory outcomes and the underlying reasoning, but also regulatory organization
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1111/jlme.12139
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 64,231
Through your library

References found in this work BETA

Transparency: The Key to Better Governance?Christopher Hood & David Heald - unknown - Proceedings of the British Academy 135.
Pharmaceutical Knowledge Governance: A Human Rights Perspective.Trudo Lemmens - 2013 - Journal of Law, Medicine and Ethics 41 (1):163-184.
Pharmaceutical Knowledge Governance: A Human Rights Perspective.Trudo Lemmens - 2013 - Journal of Law, Medicine and Ethics 41 (1):163-184.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

The Precautionary Principle and the Regulation of U.S. Food and Drug Safety.Ed Soule - 2004 - Journal of Medicine and Philosophy 29 (3):333 – 350.
Five Un‐Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.

Analytics

Added to PP index
2014-07-17

Total views
15 ( #678,959 of 2,455,410 )

Recent downloads (6 months)
1 ( #449,205 of 2,455,410 )

How can I increase my downloads?

Downloads

My notes